Giuseppe Floresta published a PDF document on figshare in May 2026, analyzing the pharmacological interplay between xylazine and tolazoline. The 547.9 KB file combines molecular docking, molecular dynamics simulations, and in silico ADME/Tox predictions to elucidate binding mechanisms and pharmacokinetic profiles. The findings offer insights into the reversal of xylazine intoxication.
Use Cases
- Validate competitive binding mechanisms at serotonin 5-HT7 and κ-opioid receptors based on the described molecular docking results.
- Compare pharmacokinetic profiles for blood-brain barrier penetration and protein binding based on the in silico ADME predictions.
- Generate testable predictions for transporter-mediated dynamics and PK/PD modeling based on the integrated receptor-level and kinetic analysis.
Strengths
- The analysis integrates multiple computational methods: molecular docking, molecular dynamics, and ADME/Tox predictions.
- The document provides a mechanistic rationale for tolazoline's clinical efficacy as an antidote, supported by the described findings.
Limitations
- The dataset is a single PDF document of 547.9 KB; its scope is limited to the described computational study.
- Column-level documentation is absent; field semantics must be inferred from the text.
- Row count is unknown, which may limit suitability assessment.
Provenance
- Source
- Giuseppe Floresta
- Collection Method
- Computational analysis combining molecular docking, molecular dynamics simulations, and in silico ADME/Tox predictions.
- Freshness
- Last updated 2026-05-21 05:42:30; freshness should be verified.